Skip to content

Clinical trials

Phase 3 Hemorrhage trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 3 Clear all

163 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20044
20055
20064
20075
20087
20098
20107
20112
20126
20139
201413
201510
20166
20176
20187
20199
20206
20218
20227
20234
20245
202510
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed92
Unknown status20
Recruiting19
Terminated11
Not yet recruiting9
Withdrawn7
Active, not recruiting3
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ethicon, Inc.5
Hamilton Health Sciences Corporation5
Astellas Pharma Inc4
Boehringer Ingelheim4
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau4
London School of Hygiene and Tropical Medicine4
Takeda4
AO GENERIUM3
Assistance Publique - Hôpitaux de Paris3
McMaster University3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage163
Thrombosis9
Venous Thromboembolism9
Atrial Fibrillation8
Blood Loss, Surgical8
Purpura, Thrombocytopenic, Idiopathic8
Wounds and Injuries8
Stroke7
Shock, Hemorrhagic6
Thrombocytopenia6

Trials

Showing 51 to 75 of 163. Each trial links to its page on Pharma Observatory.

63 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.